Codiak BioSciences, Inc. IPO Research Information

Codiak BioSciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Codiak BioSciences, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Codiak BioSciences, Inc.	CDAK - NASDAQ	$14.00-$16.00	$15.00	$14.10	5.5 million	10/14/2020
Underwriter(s): Goldman Sachs, Evercore ISI, William Blair
Co-Manager(s): WedBush PacGrow
Industry: Health Care
Filing(s): Filed 2020-09-09 Terms Added 2020-10-07

Codiak BioSciences, Inc. Quote & Chart - Click for current quote - CDAK

About Codiak BioSciences, Inc. (adapted from Codiak BioSciences, Inc. prospectus):
Codiak BioSciences is harnessing exosomes "natural intercellular messengers" to pioneer a new class of biologic medicines, exosome therapeutics.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CDAK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.